Prediction of Clearance in Children from Adults Following Drug-Drug Interaction Studies: Application of Age-Dependent Exponent Model

Overview

Journal Drugs R D

Specialty Pharmacology

Date 2020 Feb 15

PMID 32056156

Citations 1

Authors

Iftekhar Mahmood

Affiliations

Soon will be listed here.

Abstract

Background And Objective: Pharmacokinetic drug-drug interaction (DDI) studies are conducted in adult subjects during drug development but there are limited studies that have characterized pharmacokinetic DDI studies in children. The objective of this study was to evaluate if the DDI clearance values from adults can be allometrically extrapolated from adults to children.

Methods: Fifteen drugs were included in this study and the age of the children ranged from premature neonates to adolescents (30 observations across the age groups). The age-dependent exponent (ADE) model was used to predict the clearance of drugs in children from adults following DDI studies.

Results: The prediction error of drug clearances following DDIs in children ranged from 4 to 67%. Of 30 observations, 17 (57%) and 27 (90%) observations had a prediction error ≤ 30% and ≤ 50%, respectively.

Conclusion: This study indicates that it is possible to predict the clearance of drugs with reasonable accuracy in children from adults following DDI studies using an ADE model. The method is simple, robust, and reliable and can replace other complex empirical models.

Citing Articles

A comparison of different methods for the first-in-pediatric dose selection.

Mahmood I J Clin Transl Res. 2022; 8(5):369-381.

PMID: 36518546 PMC: 9741938.

References

Mahmood I, Ahmad T, Mansoor N, Sharib S . Prediction of Clearance in Neonates and Infants (≤ 3 Months of Age) for Drugs That Are Glucuronidated: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling. J Clin Pharmacol. 2016; 57(4):476-483. DOI: 10.1002/jcph.837. View

Bhatia M, Militano O, Jin Z, Figurski M, Shaw L, Moore V . An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2009; 16(3):333-43. DOI: 10.1016/j.bbmt.2009.10.007. View

Lum B, Kaubisch S, Yahanda A, Adler K, Jew L, Ehsan M . Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance. J Clin Oncol. 1992; 10(10):1635-42. DOI: 10.1200/JCO.1992.10.10.1635. View

Barry M, Howe J, Ormesher S, Back D, Breckenridge A, Bergin C . Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in patients with the acquired immunodeficiency syndrome. Br J Clin Pharmacol. 1994; 37(5):421-6. PMC: 1364896. DOI: 10.1111/j.1365-2125.1994.tb05708.x. View

Mikaeloff Y, Rey E, Soufflet C, dAthis P, Echenne B, Vallee L . Topiramate pharmacokinetics in children with epilepsy aged from 6 months to 4 years. Epilepsia. 2004; 45(11):1448-52. DOI: 10.1111/j.0013-9580.2004.65503.x. View

Hermann M, Asberg A, Reubsaet J, Sather S, Berg K, Christensen H . Intake of grapefruit juice alters the metabolic pattern of cyclosporin A in renal transplant recipients. Int J Clin Pharmacol Ther. 2002; 40(10):451-6. DOI: 10.5414/cpp40451. View

Ratnapalan S, Griffiths K, Costei A, Benson L, Koren G . Digoxin-carvedilol interactions in children. J Pediatr. 2003; 142(5):572-4. DOI: 10.1067/mpd.2003.160. View

Alcorn J, McNamara P . Ontogeny of hepatic and renal systemic clearance pathways in infants: part II. Clin Pharmacokinet. 2002; 41(13):1077-94. DOI: 10.2165/00003088-200241130-00005. View

Kersting G, Willmann S, Wurthwein G, Lippert J, Boos J, Hempel G . Physiologically based pharmacokinetic modelling of high- and low-dose etoposide: from adults to children. Cancer Chemother Pharmacol. 2011; 69(2):397-405. DOI: 10.1007/s00280-011-1706-9. View

10.

Bartelink I, Boelens J, Bredius R, Egberts A, Wang C, Bierings M . Body weight-dependent pharmacokinetics of busulfan in paediatric haematopoietic stem cell transplantation patients: towards individualized dosing. Clin Pharmacokinet. 2012; 51(5):331-45. DOI: 10.2165/11598180-000000000-00000. View

11.

Dahlin M, Wide K, Ohman I . Age and comedications influence levetiracetam pharmacokinetics in children. Pediatr Neurol. 2010; 43(4):231-5. DOI: 10.1016/j.pediatrneurol.2010.05.008. View

12.

Salerno S, Burckart G, Huang S, Gonzalez D . Pediatric Drug-Drug Interaction Studies: Barriers and Opportunities. Clin Pharmacol Ther. 2018; 105(5):1067-1070. PMC: 6465091. DOI: 10.1002/cpt.1234. View

13.

Chen C, Casale E, Duncan B, Culverhouse E, Gilman J . Pharmacokinetics of lamotrigine in children in the absence of other antiepileptic drugs. Pharmacotherapy. 1999; 19(4):437-41. DOI: 10.1592/phco.19.6.437.31052. View

14.

Battino D, Croci D, Granata T, Mamoli D, Messina S, Perucca E . Single-dose pharmacokinetics of lamotrigine in children: influence of age and antiepileptic comedication. Ther Drug Monit. 2001; 23(3):217-22. DOI: 10.1097/00007691-200106000-00006. View

15.

Arant Jr B . Developmental patterns of renal functional maturation compared in the human neonate. J Pediatr. 1978; 92(5):705-12. DOI: 10.1016/s0022-3476(78)80133-4. View

16.

Niederhauser V . Prescribing for children: issues in pediatric pharmacology. Nurse Pract. 1997; 22(3):16-8, 23, 26-8 passim. View

17.

Saccar C, Danish M, Ragni M, Rocci Jr M, Greene J, Yaffe S . The effect of phenobarbital on theophylline disposition in children with asthma. J Allergy Clin Immunol. 1985; 75(6):716-9. DOI: 10.1016/0091-6749(85)90099-5. View

18.

Mahmood I . Mechanistic versus allometric models for the prediction of drug clearance in neonates (<3 months of age). J Clin Pharmacol. 2015; 55(6):718-20. DOI: 10.1002/jcph.487. View

19.

Huang L, Carey V, Lindsey J, Marzan F, Gingrich D, Graham B . Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children. PLoS One. 2017; 12(10):e0186589. PMC: 5655345. DOI: 10.1371/journal.pone.0186589. View

20.

Wermeling D, Field C, Smith D, CHANDLER M, Clifton G, Boyle D . Effects of long-term oral carvedilol on the steady-state pharmacokinetics of oral digoxin in patients with mild to moderate hypertension. Pharmacotherapy. 1994; 14(5):600-6. View